Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

New reports from the Food and Drug Administration (FDA) and cancer patients have put Revlimid, an oral medicine given to patients with multiple myeloma, on a list of medications that could possibly cause Stevens Johnson Syndrome when used by itself or mixed with other drugs. Stevens Johnson syndrome is a serious, potentially life-threatening skin disease that can start with flu-like symptoms and eventually cause a rash that spreads and blisters.

Read the rest of this entry »

The FDA’s post-market safety review has uncovered a link between lenalidomide (marketed as the drug Revlimid) and serious skin reactions, including Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN).

Read the rest of this entry »